Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2001 1
2002 12
2003 14
2004 11
2005 12
2006 11
2007 12
2008 9
2009 12
2010 17
2011 17
2012 11
2013 11
2014 10
2015 9
2016 11
2017 10
2018 6
2019 12
2020 6
2021 15
2022 13
2023 14
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

241 results

Results by year

Filters applied: . Clear all
Page 1
Glomerular hyperfiltration.
Cortinovis M, Perico N, Ruggenenti P, Remuzzi A, Remuzzi G. Cortinovis M, et al. Among authors: ruggenenti p. Nat Rev Nephrol. 2022 Jul;18(7):435-451. doi: 10.1038/s41581-022-00559-y. Epub 2022 Apr 1. Nat Rev Nephrol. 2022. PMID: 35365815 Review.
Rituximab in steroid-dependent or frequently relapsing idiopathic nephrotic syndrome.
Ruggenenti P, Ruggiero B, Cravedi P, Vivarelli M, Massella L, Marasà M, Chianca A, Rubis N, Ene-Iordache B, Rudnicki M, Pollastro RM, Capasso G, Pisani A, Pennesi M, Emma F, Remuzzi G; Rituximab in Nephrotic Syndrome of Steroid-Dependent or Frequently Relapsing Minimal Change Disease Or Focal Segmental Glomerulosclerosis (NEMO) Study Group. Ruggenenti P, et al. J Am Soc Nephrol. 2014 Apr;25(4):850-63. doi: 10.1681/ASN.2013030251. Epub 2014 Jan 30. J Am Soc Nephrol. 2014. PMID: 24480824 Free PMC article. Clinical Trial.
Mayo Clinic consensus report on membranous nephropathy: proposal for a novel classification.
Sethi S, Beck LH Jr, Glassock RJ, Haas M, De Vriese AS, Caza TN, Hoxha E, Lambeau G, Tomas NM, Madden B, Debiec H, D'Agati VD, Alexander MP, Amer H, Appel GB, Barbour SJ, Caravaca-Fontan F, Cattran DC, Casal Moura M, D'Avila DO, Eick RG, Garovic VD, Greene EL, Herrera Hernandez LP, Jennette JC, Lieske JC, Markowitz GS, Nath KA, Nasr SH, Nast CC, Pani A, Praga M, Remuzzi G, Rennke HG, Ruggenenti P, Roccatello D, Soler MJ, Specks U, Stahl RAK, Singh RD, Theis JD, Velosa JA, Wetzels JFM, Winearls CG, Yandian F, Zand L, Ronco P, Fervenza FC. Sethi S, et al. Among authors: ruggenenti p. Kidney Int. 2023 Dec;104(6):1092-1102. doi: 10.1016/j.kint.2023.06.032. Epub 2023 Oct 5. Kidney Int. 2023. PMID: 37795587 Free article.
Safety and Preliminary Efficacy of Mesenchymal Stromal Cell (ORBCEL-M) Therapy in Diabetic Kidney Disease: A Randomized Clinical Trial (NEPHSTROM).
Perico N, Remuzzi G, Griffin MD, Cockwell P, Maxwell AP, Casiraghi F, Rubis N, Peracchi T, Villa A, Todeschini M, Carrara F, Magee BA, Ruggenenti PL, Rota S, Cappelletti L, McInerney V, Griffin TP, Islam MN, Introna M, Pedrini O, Golay J, Finnerty AA, Smythe J, Fibbe WE, Elliman SJ, O'Brien T; NEPHSTROM Trial Consortium. Perico N, et al. Among authors: ruggenenti pl. J Am Soc Nephrol. 2023 Oct 1;34(10):1733-1751. doi: 10.1681/ASN.0000000000000189. Epub 2023 Aug 10. J Am Soc Nephrol. 2023. PMID: 37560967 Clinical Trial.
Vaccination Recommendations in Solid Organ Transplant Adult Candidates and Recipients.
Viganò M, Beretta M, Lepore M, Abete R, Benatti SV, Grassini MV, Camagni S, Chiodini G, Vargiu S, Vittori C, Iachini M, Terzi A, Neri F, Pinelli D, Casotti V, Di Marco F, Ruggenenti P, Rizzi M, Colledan M, Fagiuoli S. Viganò M, et al. Among authors: ruggenenti p. Vaccines (Basel). 2023 Oct 18;11(10):1611. doi: 10.3390/vaccines11101611. Vaccines (Basel). 2023. PMID: 37897013 Free PMC article. Review.
Estimated GFR: time for a critical appraisal.
Porrini E, Ruggenenti P, Luis-Lima S, Carrara F, Jiménez A, de Vries APJ, Torres A, Gaspari F, Remuzzi G. Porrini E, et al. Among authors: ruggenenti p. Nat Rev Nephrol. 2019 Mar;15(3):177-190. doi: 10.1038/s41581-018-0080-9. Nat Rev Nephrol. 2019. PMID: 30518813 Review.
Mechanisms and treatment of CKD.
Ruggenenti P, Cravedi P, Remuzzi G. Ruggenenti P, et al. J Am Soc Nephrol. 2012 Dec;23(12):1917-28. doi: 10.1681/ASN.2012040390. Epub 2012 Oct 25. J Am Soc Nephrol. 2012. PMID: 23100218 Review.
Proteinuria should be used as a surrogate in CKD.
Cravedi P, Ruggenenti P, Remuzzi G. Cravedi P, et al. Among authors: ruggenenti p. Nat Rev Nephrol. 2012 Mar 6;8(5):301-6. doi: 10.1038/nrneph.2012.42. Nat Rev Nephrol. 2012. PMID: 22391456 Review.
241 results